Latin America PoC Infectious Disease Testing Market Size, Share & Trends Analysis Report By Type, By Disease, By End-use, By Country, And Segment Forecasts, 2024

The Latin America PoC infectious disease testing market size is expected to reach USD 1.1 billion by 2030 and is projected to grow at a CAGR of 2.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is driven by several key factors, including high disease prevalence, advancements in diagnostic technology, and supportive regulatory and governmental initiatives. The region continues to face a high burden of infectious diseases such as malaria, tuberculosis (TB), HIV, and neglected tropical diseases. According to the Pan American Health Organization (PAHO), diseases like dengue fever, Zika virus, and Chagas disease are endemic in LATAM, significantly impacting public health and creating a persistent demand for effective diagnostic tools.

Recent developments in diagnostic technology have also played a crucial role. Innovations such as rapid diagnostic tests (RDTs) and molecular assays have enhanced the speed and accuracy of disease detection. For instance, advances in CRISPR-based diagnostics and next-generation sequencing are improving the sensitivity of tests, which is crucial for managing infectious disease outbreaks and providing timely treatment.

Government and international initiatives further drive market growth. In response to the high disease burden, Latin American governments and organizations are implementing strategic health programs. The Brazilian Ministry of Health's "Healthy Brazil" initiative and Colombia's Disease Elimination Initiative are notable examples. These programs focus on improving disease control measures and expanding diagnostic capabilities. Additionally, international organizations like the Global Fund and PAHO are providing financial support and technical assistance, bolstering the infrastructure for disease testing and management.

Latin America PoC Infectious Disease Testing Market Report Highlights:

Based on type, the PoC rapid diagnostic single test segment dominated the market with more than 70% of revenue share in 2023, driven by its practicality and effectiveness.
Based on disease, the COVID-19 segment dominated the market and accounted for 45.8% of the total share in 2023. This dominance is primarily driven by several factors, including the continued impact of the pandemic, high testing demand, and significant advancements in diagnostic technology.
Based on end use, the clinics segment held the largest share of 37.5% in 2023. Clinics are pivotal in providing primary healthcare services, including diagnostic testing for infectious diseases.
In May 2024, BioPerfectus received approval from Brazil's ANVISA for its dengue and malaria diagnostic kits. In collaboration with the China CDC, the company developed the Malaria Pf/Pan (HRP2/pLDH) Antigen Rapid Test Kit, supplied to Papua New Guinea, to support local efforts in managing infectious diseases.

Product Code: GVR-4-68040-458-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Disease
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in Latin America
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type
- 2.2.2. Disease
- 2.2.3. End Use
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Latin America Point of Care (PoC) Infectious Disease Testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. High Disease Prevalence
  - 3.2.1.2. Technological Advancements
  - 3.2.1.3. Government and International Initiatives
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Limited Healthcare Access
  - 3.2.2.2. Regulatory and Approval Challenges
3.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Estimates & Trend Analysis

4.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Dashboard
4.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Movement Analysis
4.3. Latin America Point of Care (PoC) Infectious Disease Testing Market by Type, Revenue
4.4. POC Rapid Diagnostic Single-test
- 4.4.1. POC Rapid Diagnostic Single-test market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. POC Rapid Diagnostic Combo-test
- 4.5.1. POC Rapid Diagnostic Combo-test market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Estimates & Trend Analysis

5.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Dashboard
5.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Movement Analysis
5.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Estimates and Forecasts, By Disease, Revenue (USD Million)
5.4. HIV POC
- 5.4.1. HIV POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Chlamydia & Gonorrhea
- 5.5.1. Chlamydia & Gonorrhea only market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Adenovirus
- 5.6.1. Adenovirus market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Rotavirus
- 5.7.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Norovirus
- 5.8.1. 5.5. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Shigella
- 5.9.1. Shigella market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Dengue
- 5.10.1. Dengue market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Zika
- 5.11.1. Zika market estimates and forecasts, 2018 to 2030 (USD Million)
5.12. Typhoid
- 5.12.1. Typhoid market estimates and forecasts, 2018 to 2030 (USD Million)
5.13. Syphilis
- 5.13.1. Syphilis market estimates and forecasts, 2018 to 2030 (USD Million)
5.14. Malaria
- 5.14.1. Malaria market estimates and forecasts, 2018 to 2030 (USD Million)
5.15. Anti-TP (Treponema pallidum)
- 5.15.1. Anti-TP (Treponema pallidum) market estimates and forecasts, 2018 to 2030 (USD Million)
5.16. Monkeypox
- 5.16.1. Monkeypox market estimates and forecasts, 2018 to 2030 (USD Million)
5.17. Strep A
- 5.17.1. Strep A market estimates and forecasts, 2018 to 2030 (USD Million)
5.18. H. pylori
- 5.18.1. H. pylori market estimates and forecasts, 2018 to 2030 (USD Million)
5.19. HBV POC
- 5.19.1. HBV POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.20. Pneumonia Or Streptococcus Associated Infections
- 5.20.1. Pneumonia Or Streptococcus Associated Infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.21. Respiratory Syncytial Virus (RSV) POC
- 5.21.1. Respiratory Syncytial Virus (RSV) POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.22. HPV POC
- 5.22.1. HPV POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.23. Influenza/Flu POC
- 5.23.1. Influenza/Flu POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.24. HCV POC
- 5.24.1. HCV POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.25. MRSA POC
- 5.25.1. MRSA POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.26. TB & Drug-resistant TB POC
- 5.26.1. TB & Drug-resistant TB POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.27. HSV POC
- 5.27.1. HSV POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.28. COVID-19
- 5.28.1. COVID-19 POC market estimates and forecasts, 2018 to 2030 (USD Million)
5.29. Other Infectious Diseases
- 5.29.1. Other Infectious Diseases POC market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Estimates & Trend Analysis

6.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Sales Indication Dashboard
6.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Sales Indication Movement Analysis
6.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Estimates and Forecasts, By Sales Indication, Revenue (USD Million)
6.4. Clinics
- 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Hospitals
- 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Home
- 6.6.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Assisted Living Healthcare Facilities
- 6.7.1. Assisted Living Healthcare Facilities market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Laboratory
- 6.8.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Latin America Point of Care (PoC) Infectious Disease Testing Market: Regional Estimates & Trend Analysis by Type, Disease, and End Use

7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. Latin America
- 7.3.1. Brazil
  - 7.3.1.1. Key country dynamics
  - 7.3.1.2. Regulatory framework/ reimbursement structure
  - 7.3.1.3. Competitive scenario
  - 7.3.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.2. Argentina
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework/ reimbursement structure
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.3. Rest of LATAM
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework/ reimbursement structure
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Rest of LATAM market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Vendor Landscape
- 8.2.1. List of key distributors and channel partners
- 8.2.2. Key company market share analysis, 2023
- 8.2.3. InTec Products, Inc.
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Assure Tech (Hangzhou) Co., Ltd
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. Getein Biotech, Inc.
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. Xiamen Biotime Biotechnology Co., Ltd.
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. Nantong Egens Biotechnology Co., Ltd.
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. Xiamen Boson Biotech Co., Ltd.
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. F Hoffman-La Roche Ltd.
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives
- 8.2.10. Abbott
  - 8.2.10.1. Company overview
  - 8.2.10.2. Financial performance
  - 8.2.10.3. Product benchmarking
  - 8.2.10.4. Strategic initiatives
- 8.2.11. Thermo Fisher Scientific, Inc.
  - 8.2.11.1. Company overview
  - 8.2.11.2. Financial performance
  - 8.2.11.3. Product benchmarking
  - 8.2.11.4. Strategic initiatives
- 8.2.12. Siemens Healthcare AG
  - 8.2.12.1. Company overview
  - 8.2.12.2. Financial performance
  - 8.2.12.3. Product benchmarking
  - 8.2.12.4. Strategic initiatives
- 8.2.13. Becton, Dickinson, and Company (BD)
  - 8.2.13.1. Company overview
  - 8.2.13.2. Financial performance
  - 8.2.13.3. Product benchmarking
  - 8.2.13.4. Strategic initiatives
- 8.2.14. CTK Biotech
  - 8.2.14.1. Company overview
  - 8.2.14.2. Financial performance
  - 8.2.14.3. Product benchmarking
  - 8.2.14.4. Strategic initiatives

Product Code: GVR-4-68040-458-8

List of Tables

Table 1 List Of Abbreviation
Table 2 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Region, 2018 - 2030 (USD Million)
Table 3 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
Table 4 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
Table 5 Latin America Point of Care (PoC) Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 6 Brazil PoC Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
Table 7 Brazil PoC Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
Table 8 Brazil PoC Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 9 Argentina PoC Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
Table 10 Argentina PoC Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
Table 11 Argentina PoC Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 12 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
Table 13 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
Table 14 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Latin America Point of Care (PoC) Infectious Disease Testing Market: Market Outlook
Fig. 14 Latin America Point of Care (PoC) Infectious Disease Testing Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Latin America Point of Care (PoC) Infectious Disease Testing Market Driver Impact
Fig. 18 Latin America Point of Care (PoC) Infectious Disease Testing Market Restraint Impact
Fig. 19 Latin America Point of Care (PoC) Infectious Disease Testing Market Strategic Initiatives Analysis
Fig. 20 Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Movement Analysis
Fig. 21 Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Outlook And Key Takeaways
Fig. 22 POC rapid diagnostic single-test market estimates and forecast, 2018 - 2030
Fig. 23 POC rapid diagnostic combo-test market estimates and forecast, 2018 - 2030
Fig. 24 Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Movement Analysis
Fig. 25 Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Outlook And Key Takeaways
Fig. 26 HIV POC market estimates and forecast, 2018 - 2030
Fig. 27 Chlamydia & gonorrhea market estimates and forecast, 2018 - 2030
Fig. 28 Adenovirus market estimates and forecast, 2018 - 2030
Fig. 29 Rotavirus market estimates and forecast, 2018 - 2030
Fig. 30 Norovirus market estimates and forecast, 2018 - 2030
Fig. 31 Shigella market estimates and forecast, 2018 - 2030
Fig. 32 Dengue market estimates and forecast, 2018 - 2030
Fig. 33 Zika market estimates and forecast, 2018 - 2030
Fig. 34 Syphilis market estimates and forecast, 2018 - 2030
Fig. 35 Malaria market estimates and forecast, 2018 - 2030
Fig. 36 Anti-TP (Treponema pallidum) market estimates and forecast, 2018 - 2030
Fig. 37 Monkeypox market estimates and forecast, 2018 - 2030
Fig. 38 Strep A market estimates and forecast, 2018 - 2030
Fig. 39 H. pylori market estimates and forecast, 2018 - 2030
Fig. 40 HBV POC market estimates and forecast, 2018 - 2030
Fig. 41 Pneumonia or streptococcus associated infections market estimates and forecast, 2018 - 2030
Fig. 42 Respiratory Syncytial Virus (RSV) POC market estimates and forecast, 2018 - 2030
Fig. 43 HPV POC market estimates and forecast, 2018 - 2030
Fig. 44 Influenza/Flu POC market estimates and forecast, 2018 - 2030
Fig. 45 HCV POC market estimates and forecast, 2018 - 2030
Fig. 46 MRSA POC market estimates and forecast, 2018 - 2030
Fig. 47 TB & Drug-resistant TB POC market estimates and forecast, 2018 - 2030
Fig. 48 HSV POC market estimates and forecast, 2018 - 2030
Fig. 49 COVID-19 market estimates and forecast, 2018 - 2030
Fig. 50 Other Infectious Diseases market estimates and forecast, 2018 - 2030
Fig. 51 Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Movement Analysis
Fig. 52 Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Outlook And Key Takeaways
Fig. 53 Clinics market estimates and forecast, 2018 - 2030
Fig. 54 Hospitals market estimates and forecast, 2018 - 2030
Fig. 55 Home market estimates and forecast, 2018 - 2030
Fig. 56 Assisted Living Healthcare Facilities market estimates and forecast, 2018 - 2030
Fig. 57 Laboratory market estimates and forecast, 2018 - 2030
Fig. 58 LATAM market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Brazil key country dynamics
Fig. 60 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Argentina key country dynamics
Fig. 62 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Rest of LATAM key country dynamics
Fig. 64 Rest of LATAM market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Market share of key market players - Pet insurance market

Latin America PoC Infectious Disease Testing Market Size, Share & Trends Analysis Report By Type, By Disease, By End-use, By Country, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

Latin America PoC Infectious Disease Testing Market Growth & Trends:

Latin America PoC Infectious Disease Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Latin America Point of Care (PoC) Infectious Disease Testing Market Variables, Trends & Scope

Chapter 4. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Estimates & Trend Analysis

Chapter 5. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Estimates & Trend Analysis

Chapter 6. Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Estimates & Trend Analysis

Chapter 7. Latin America Point of Care (PoC) Infectious Disease Testing Market: Regional Estimates & Trend Analysis by Type, Disease, and End Use

Chapter 8. Competitive Landscape

List of Tables

List of Figures